{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:22:22Z","timestamp":1793413342032,"version":"4.5.0"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019304","name":"Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019305","name":"Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmech.2025.118540","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T07:40:15Z","timestamp":1767080415000},"page":"118540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Scaffold optimization trends in matrix metalloproteinase inhibitors for selective pancreatic cancer Therapy\u2014A review"],"prefix":"10.1016","volume":"305","author":[{"given":"Kyathi","family":"Kolli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3418-4325","authenticated-orcid":false,"given":"Dileep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118540_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc1821","article-title":"Tumor microenvironment opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy","volume":"6","author":"Overall","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.118540_bib2","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","article-title":"Pancreatic cancer","volume":"362","author":"Hidalgo","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.118540_bib3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmech.2025.118540_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling","volume":"8","author":"Page-McCaw","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118540_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1006\/scbi.2000.0379","article-title":"Matrix metalloproteinases in tumor invasion and metastasis","volume":"10","author":"Stamenkovic","year":"2000","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejmech.2025.118540_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","article-title":"How matrix metalloproteinases regulate cell behavior","volume":"17","author":"Sternlicht","year":"2001","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2025.118540_bib7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1902\/jop.1993.64.5.474","article-title":"Role of matrix metalloproteinases in human periodontal diseases","volume":"64","author":"Birkedal-Hansen","year":"1993","journal-title":"J. Periodontol."},{"key":"10.1016\/j.ejmech.2025.118540_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/path.2282","article-title":"Cancer invasion and metastasis: changing views","volume":"214","author":"Duffy","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejmech.2025.118540_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118540_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.gendis.2014.12.002","article-title":"Targeting matrix metalloproteinases in cancer: bringing new life to old ideas","volume":"2","author":"Cathcart","year":"2015","journal-title":"Genes Dis."},{"key":"10.1016\/j.ejmech.2025.118540_bib11","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1007\/s00018-011-0763-x","article-title":"Matrix metalloproteinases in tumorigenesis: an evolving paradigm","volume":"68","author":"Hua","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2025.118540_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.matbio.2015.03.004","article-title":"Membrane-type matrix metalloproteinases: their functions and regulations","volume":"44\u201346","author":"Itoh","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ejmech.2025.118540_bib13","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/cells8090984","article-title":"The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma","volume":"8","author":"Fields","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.118540_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00726-010-0689-x","article-title":"Physiology and pathophysiology of matrix metalloproteases","volume":"41","author":"Klein","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejmech.2025.118540_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/gb-2011-12-11-233","article-title":"Tissue inhibitors of metalloproteinases","volume":"12","author":"Murphy","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.ejmech.2025.118540_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","article-title":"The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity","volume":"1803","author":"Brew","year":"2010","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejmech.2025.118540_bib17","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005058","article-title":"Extracellular matrix degradation and remodeling in development and disease","volume":"3","author":"Lu","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ejmech.2025.118540_bib18","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.2741\/4365","article-title":"MMP inhibitors: past, present and future","volume":"20","author":"Cathcart","year":"2015","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejmech.2025.118540_bib19","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/cbic.201200298","article-title":"Chemical biology for understanding matrix metalloproteinase function","volume":"13","author":"Knapinska","year":"2012","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2025.118540_bib20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.biochi.2004.11.019","article-title":"Crystal structures of MMPs: what do they tell us about function?","volume":"87","author":"Maskos","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2025.118540_bib21","first-page":"647","article-title":"Matrix metalloproteinases and their inhibitors in cancer therapy: an update","volume":"28","author":"Zucker","year":"2009","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ejmech.2025.118540_bib22","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nrd2308","article-title":"Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases","volume":"6","author":"Hu","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118540_bib23","first-page":"205","article-title":"MMPs as therapeutic targets: opportunities and challenges","volume":"9","author":"Bergers","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118540_bib24","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.matbio.2007.07.001","article-title":"Control of matrix metalloproteinase catalytic activity","volume":"26","author":"Ra","year":"2007","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ejmech.2025.118540_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/138161207779313551","article-title":"Matrix metalloproteinases as valid clinical targets","volume":"13","author":"Fingleton","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2025.118540_bib27","first-page":"215","article-title":"Clinical studies with matrix metalloproteinase inhibitors","volume":"19","author":"Brown","year":"1998","journal-title":"AAPS J."},{"key":"10.1016\/j.ejmech.2025.118540_bib28","first-page":"1743","article-title":"Marimastat as first oral MMP inhibitor in pancreatic cancer","volume":"86","author":"Bramhall","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2025.118540_bib29","first-page":"865","article-title":"Structural basis for selectivity of batimastat, a hydroxamate inhibitor","volume":"290","author":"Dhanaraj","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.118540_bib30","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1021\/cr9804543","article-title":"Design and therapeutic application of matrix metalloproteinase inhibitors","volume":"99","author":"Whittaker","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.118540_bib31","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.2174\/0929867043364018","article-title":"The design, structure, and therapeutic application of matrix metalloproteinase inhibitors","volume":"11","author":"Skiles","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib32","first-page":"422","article-title":"Matrix metalloproteinase inhibitors: new challenges in the era of precision medicine","volume":"142","author":"Nuti","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib33","first-page":"165","article-title":"Design of phosphinic peptide inhibitors for MMPs: transition-state analogs","volume":"2","author":"Dive","year":"1995","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118540_bib34","first-page":"1945","article-title":"Insight into MMP catalytic site plasticity: selectivity via S1\u2032 subsite targeting","volume":"11","author":"Devel","year":"2010","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2025.118540_bib35","first-page":"309","article-title":"The S1\u2032 pocket of MMPs: determinant of selectivity","volume":"83","author":"Lang","year":"2001","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2025.118540_bib36","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/1521-3773(20020802)41:15<2644::AID-ANIE2644>3.0.CO;2-O","article-title":"Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors","volume":"41","author":"Gohlke","year":"2002","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.118540_bib37","first-page":"3044","article-title":"Structural optimization of hydroxamate inhibitors targeting MMP-2 and MMP-9","volume":"45","author":"Ndinguri","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib38","first-page":"1367","article-title":"Hydroxamate-type arylsulfonamide MMP inhibitors: synthesis and SAR","volume":"11","author":"Mori","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib39","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1016\/j.bmcl.2003.10.026","article-title":"Tetrahydroisoquinoline-based sulfonamide hydroxamates as potent MMP inhibitors","volume":"14","author":"Ma","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118540_bib40","first-page":"1879","article-title":"Hydroxamic acid derivatives with improved MMP-12 selectivity","volume":"47","author":"Jeng","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib41","first-page":"2102","article-title":"Biphenylsulfonamido hydroxamates as selective MMP-12 inhibitors","volume":"50","author":"Nuti","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib42","first-page":"1478","article-title":"Radiolabeled hydroxamate-based MMP-12 inhibitors as imaging probes","volume":"21","author":"Gona","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib43","first-page":"1045","article-title":"Structural basis for hydroxamate selectivity in MMP-12 inhibition","volume":"16","author":"Pochetti","year":"2009","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118540_bib44","first-page":"1","article-title":"Optimization of sulfonamide-based inhibitors targeting MMP-12","volume":"65","author":"Chen","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib45","first-page":"204","article-title":"Arylsulfone hydroxamates as potent and selective MMP-12 inhibitors","volume":"85","author":"Hu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib46","first-page":"136","article-title":"Structural and kinetic characterization of potent MMP-12-selective inhibitors","volume":"8","author":"Devel","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118540_bib47","first-page":"203","article-title":"Pharmacophore modeling and molecular docking for selective MMP-12 inhibitors","volume":"121","author":"Nuti","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib48","first-page":"2931","article-title":"From hydroxamates to non-zinc chelating MMP inhibitors","volume":"25","author":"Rossello","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib49","first-page":"1501","article-title":"MMP inhibitors: Structure-Based optimization of phosphinic peptides","volume":"92","author":"Dive","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2025.118540_bib50","first-page":"1108","article-title":"Phosphinate peptide inhibitors of MMPs: synthesis and evaluation","volume":"52","author":"Makaritis","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib51","first-page":"1632","article-title":"MMP-12 inhibitors with dual phosphinate-hydroxamate motifs","volume":"28","author":"Yu","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118540_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","article-title":"Roles of MMPs in cancer progression and their pharmacological targeting","volume":"278","author":"Gialeli","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2025.118540_bib53","first-page":"11997","article-title":"Crystal structures of MMP-12 in complex with inhibitors: insights into selectivity","volume":"46","author":"Hu","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118540_bib54","first-page":"1","article-title":"Aryl sulfonamide and carboxylate MMP inhibitors: structure-activity correlation","volume":"175","author":"Nuti","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib55","article-title":"Synthesis and biological evaluation of carboxylate-based MMP inhibitors","volume":"28","author":"Santos","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib56","first-page":"1117","article-title":"Peptidic and non-peptidic carboxylate inhibitors of MMPs","volume":"2","author":"Yiotakis","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib57","first-page":"4577","article-title":"Structural optimization of phosphinic peptide inhibitors targeting MMP-12","volume":"52","author":"Ndinguri","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib58","first-page":"2430","article-title":"Structure-based optimization of phosphinic peptides for MMP-12 inhibition","volume":"19","author":"Czarny","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib59","first-page":"3079","article-title":"Inhibitor binding dynamics at the S1\u2032 site of MMP-12: a comparative study","volume":"52","author":"Arendt","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118540_bib60","first-page":"3804","article-title":"Phosphinate inhibitors for metalloproteases: from design to biological evaluation","volume":"21","author":"Yiotakis","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib61","first-page":"21","article-title":"Phosphinic peptides: versatile inhibitors of MMPs and ACE","volume":"30","author":"Dive","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib62","first-page":"823","article-title":"Recent advances in phosphinic MMP inhibitors: selectivity and pharmacokinetics","volume":"39","author":"Rossello","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118540_bib63","article-title":"Pharmacophore design of selective MMP-12 phosphinate inhibitors","volume":"206","author":"Nuti","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib64","article-title":"Structure\u2013activity relationship study of phosphinate inhibitors targeting MMP-12","volume":"44","author":"Makaritis","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib65","article-title":"Computational design of phosphinate MMP inhibitors with enhanced S1\u2032 occupancy","volume":"113","author":"Reddy","year":"2022","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2025.118540_bib69","article-title":"Phosphinic pseudopeptides as zinc metalloprotease inhibitors: rational design and evaluation","volume":"268","author":"Costa","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib70","first-page":"413","article-title":"Structural determinants of MMP inhibitor selectivity: insights from phosphinic analogs","volume":"63","author":"Dive","year":"2024","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118540_bib71","article-title":"Optimization of MMP inhibitors via structural modification of phosphinate moieties","volume":"89","author":"Hu","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118540_bib72","article-title":"Rational design of phosphinate inhibitors for PDAC: a computational approach","volume":"273","author":"Li","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib73","article-title":"Comparative SAR of phosphinate and carboxylate inhibitors targeting MMP-12","volume":"81","author":"Zhang","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib74","first-page":"941","article-title":"Discovery of phosphinate analogues with potent MMP-12 selectivity","volume":"16","author":"Jiang","year":"2025","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2025.118540_bib88","first-page":"617","article-title":"Novel thiol-based compounds as MMP-2 and MMP-9 inhibitors with anti-angiogenic properties","volume":"9","author":"Koivunen","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2025.118540_bib89","first-page":"414","article-title":"Structure\u2013activity relationship of benzothiazole-thiol inhibitors targeting MMP-12","volume":"96","author":"Yang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib90","first-page":"273","article-title":"Non-hydroxamate MMP inhibitors containing thiosemicarbazone moieties","volume":"24","author":"Dong","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib91","first-page":"103","article-title":"Thiol-containing peptidic inhibitors: synthesis and selectivity for MMP-9","volume":"32","author":"Rocca","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib92","first-page":"1123","article-title":"Crystal structures of thiol-based inhibitors reveal flexibility in the S1\u2032 pocket of MMP-12","volume":"56","author":"Yamada","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118540_bib93","first-page":"91","article-title":"Computational modeling of thiol-based inhibitors identifies key electrostatic features for selectivity","volume":"80","author":"Lee","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib94","first-page":"1553","article-title":"Development of cysteine-based selective MMP inhibitors","volume":"28","author":"Chen","year":"2019","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.118540_bib95","article-title":"Thiol-functionalized small molecules as next-generation MMP-12 inhibitors for pulmonary fibrosis","volume":"198","author":"Zhao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib96","first-page":"7068","article-title":"Carbamate-based MMP inhibitors: rational design and biological evaluation","volume":"21","author":"Carotti","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib97","first-page":"7345","article-title":"Urea-linked inhibitors as potent MMP-13 blockers","volume":"57","author":"Yang","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib98","first-page":"493","article-title":"Carbamate and urea hybrids: non-zinc-binding selective inhibitors for MMP-12","volume":"108","author":"Luo","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib99","first-page":"4241","article-title":"Discovery of selective MMP-12 inhibitors via carbamate\u2013urea hybridization","volume":"60","author":"Nuti","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib100","first-page":"3545","article-title":"Dual-acting carbamate\u2013urea inhibitors of MMP-9 and MMP-13: structural and SAR insights","volume":"26","author":"Pratesi","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib101","first-page":"431","article-title":"Carboxylic-urea hybrids with reduced cytotoxicity for MMP-12 targeting","volume":"176","author":"Costa","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib102","first-page":"2728","article-title":"Structure-based optimization of urea-linked inhibitors of MMP-12","volume":"60","author":"Marchand","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118540_bib103","article-title":"Comparative docking of urea versus hydroxamate inhibitors for MMP-9 and MMP-12","volume":"111","author":"Melchiorre","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib104","article-title":"Discovery of carbamate-based dual inhibitors targeting MMP-12 and MMP-13","volume":"17","author":"Abate","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118540_bib105","article-title":"Structure\u2013activity relationships of urea\u2013carbamate scaffolds in MMP inhibition","volume":"257","author":"Fazzini","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib106","first-page":"33","article-title":"X-ray crystal structure of carbamate-linked MMP-12 inhibitor complex","volume":"212","author":"Pochetti","year":"2023","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2025.118540_bib107","article-title":"Insights into non-zinc-chelating urea inhibitors for MMPs","volume":"265","author":"Devel","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib108","article-title":"Design and optimization of selective urea-based MMP-12 inhibitors using fragment merging","volume":"98","author":"Li","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118540_bib109","first-page":"4960","article-title":"Peptidomimetic inhibitors of MMP-12 with conformationally constrained backbones","volume":"58","author":"Takahashi","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib110","first-page":"384","article-title":"Rational design of macrocyclic inhibitors targeting MMP-9 and MMP-12","volume":"17","author":"Dive","year":"2016","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2025.118540_bib111","first-page":"3829","article-title":"Peptidomimetic MMP inhibitors: balancing potency and selectivity","volume":"24","author":"Yiotakis","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib112","first-page":"1104","article-title":"Conformational dynamics of macrocyclic peptide inhibitors of MMP-12","volume":"57","author":"Czarny","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118540_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.02.012","article-title":"Macrocyclic small molecules as potent and selective inhibitors of MMP-13","volume":"145","author":"Huang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib114","article-title":"Hybrid macrocycles with dual inhibitory profiles against MMP-9 and MMP-12","volume":"27","author":"Gialeli","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib115","article-title":"Novel peptidomimetic MMP-12 inhibitors: from design to preclinical evaluation","volume":"189","author":"Rossello","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib126","first-page":"2402","article-title":"Computational approaches in the design of MMP inhibitors: a review","volume":"24","author":"Khan","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2025.118540_bib127","first-page":"443","article-title":"Molecular docking and 3D-QSAR modeling for selective inhibition of MMP-12","volume":"163","author":"Hu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib128","first-page":"1682","article-title":"Structure\u2013activity modeling of hydroxamate and carboxylate inhibitors against MMP-12","volume":"60","author":"Verma","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118540_bib129","article-title":"Application of pharmacophore modeling in MMP inhibitor discovery","volume":"112","author":"Singh","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib130","article-title":"Integrative computational\u2013experimental design of novel MMP inhibitors","volume":"210","author":"Kaushik","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib131","first-page":"1827","article-title":"Machine learning-guided QSAR models for predicting MMP inhibition potency","volume":"62","author":"Zhang","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118540_bib132","article-title":"Deep-learning approaches for virtual screening of MMP inhibitors","volume":"119","author":"Fang","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib133","article-title":"Molecular dynamics and binding free-energy analysis of MMP-12 inhibitors","volume":"247","author":"Luo","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib134","article-title":"Docking-based pharmacophore modeling to guide MMP-12 inhibitor discovery","volume":"88","author":"Arora","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118540_bib135","article-title":"Comparative binding analysis of hydroxamate and sulfonamide inhibitors using MD simulations","volume":"124","author":"Patel","year":"2024","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2025.118540_bib136","article-title":"QSAR-based optimization of phosphinate inhibitors for MMP-12","volume":"270","author":"Reddy","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib137","article-title":"Structure-based drug design of MMP inhibitors using hybrid computational workflows","volume":"90","author":"Zhou","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib138","article-title":"Rational design and in-silico validation of selective MMP-12 inhibitors","volume":"273","author":"Li","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib139","article-title":"Computational repurposing of known drugs as MMP inhibitors for PDAC","volume":"108","author":"Kaur","year":"2024","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib171","article-title":"Multi-target molecular dynamics approach to explore MMPs in pancreatic ductal adenocarcinoma","volume":"137","author":"Patel","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib172","article-title":"Network pharmacology and docking reveal MMP inhibition as a key mechanism in PDAC suppression","volume":"268","author":"Sharma","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib173","first-page":"112","article-title":"Integrative omics reveals MMP-2 and MMP-9 upregulation in pancreatic cancer invasion","volume":"19","author":"Banerjee","year":"2023","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ejmech.2025.118540_bib174","first-page":"783","article-title":"Molecular profiling of MMP expression in pancreatic cancer progression","volume":"13","author":"Zhou","year":"2022","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.118540_bib175","article-title":"The MMP-TIMP balance in pancreatic cancer microenvironment: implications for targeted therapy","volume":"12","author":"Guo","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2025.118540_bib176","article-title":"MMP-9-mediated remodeling of the ECM enhances pancreatic tumor invasion","volume":"556","author":"Lin","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2025.118540_bib177","article-title":"Computational elucidation of MMP-12 inhibition mechanisms in PDAC metastasis","volume":"126","author":"Rane","year":"2024","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2025.118540_bib178","first-page":"256","article-title":"Role of matrix metalloproteinases in PDAC stromal crosstalk and therapeutic resistance","volume":"22","author":"Chen","year":"2024","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118540_bib179","article-title":"Inhibition of MMP-2 and MMP-9 as a therapeutic strategy for pancreatic carcinoma","volume":"277","author":"Singh","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib180","first-page":"321","article-title":"Modulation of MMP signaling suppresses metastasis in PDAC models","volume":"15","author":"Giri","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.118540_bib181","article-title":"Computational identification of lead inhibitors for MMP-9 and MMP-12 in pancreatic cancer","volume":"138","author":"Hassan","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib182","article-title":"Virtual screening and molecular docking reveal selective MMP-12 inhibitors for PDAC therapy","volume":"246","author":"Zhou","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib183","first-page":"1821","article-title":"Ligand-based design of selective inhibitors targeting MMP-9 in pancreatic tumors","volume":"63","author":"Li","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118540_bib184","article-title":"Pharmacophore-based screening for non-hydroxamate MMP inhibitors in PDAC","volume":"91","author":"Wang","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib185","article-title":"QSAR modeling of MMP inhibitors using ensemble learning approaches","volume":"108","author":"Xu","year":"2024","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib186","article-title":"Molecular dynamics simulations reveal active-site flexibility of MMP-12 in PDAC","volume":"268","author":"Saini","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib187","article-title":"Targeting MMP-mediated EMT pathways in pancreatic cancer progression","volume":"14","author":"Patel","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118540_bib188","first-page":"3142","article-title":"Crystallographic studies of MMP-12 complexed with PDAC-active inhibitors","volume":"62","author":"Yamada","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118540_bib189","article-title":"Homology modeling and MD simulation of novel MMP-12 inhibitors","volume":"1305","author":"Singh","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118540_bib190","article-title":"Insights into S1\u2032 pocket specificity in MMP-12 inhibitors: implications for PDAC therapy","volume":"269","author":"Li","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib191","article-title":"3D-QSAR and docking-driven design of novel selective MMP inhibitors","volume":"90","author":"Reddy","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib192","first-page":"4634","article-title":"Free-energy landscape of MMP inhibitors bound to PDAC-relevant isoforms","volume":"20","author":"Agarwal","year":"2024","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ejmech.2025.118540_bib193","first-page":"1156","article-title":"Integrative docking\u2013MD\u2013MM-GBSA studies for evaluating MMP-12 inhibitor potency","volume":"22","author":"Zhao","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejmech.2025.118540_bib194","article-title":"Role of MMP inhibitors in overcoming chemoresistance in pancreatic cancer","volume":"563","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2025.118540_bib195","article-title":"Dual inhibition of MMP and EGFR pathways suppresses PDAC progression","volume":"277","author":"Banik","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib196","first-page":"2769","article-title":"Mechanistic analysis of MMP-Driven desmoplasia in pancreatic tumors","volume":"18","author":"Lu","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ejmech.2025.118540_bib197","article-title":"Computational identification of MMP\u2013cytokine network disruption in PDAC","volume":"39","author":"Das","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2025.118540_bib198","article-title":"MMP inhibitors as modulators of immune-suppressive microenvironment in PDAC","volume":"15","author":"Kumar","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.118540_bib199","article-title":"Structural and energetic mapping of MMP\u2013ECM interactions in pancreatic stroma","volume":"275","author":"Xie","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib200","first-page":"225","article-title":"Targeting MMP-12 in macrophage-mediated pancreatic inflammation","volume":"22","author":"Ren","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.118540_bib201","article-title":"Computational\u2013experimental design of selective MMP inhibitors for PDAC","volume":"272","author":"Yin","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib202","article-title":"Multi-omics analysis of MMP\u2013ECM signaling in PDAC metastasis","volume":"43","author":"Wu","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2025.118540_bib203","first-page":"409","article-title":"The metalloprotease landscape of pancreatic cancer: emerging therapeutic targets","volume":"23","author":"Barai","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2025.118540_bib204","article-title":"Clinical landscape of MMP inhibitors: from BB-94 to AZD1236","volume":"244","author":"Rossi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib205","first-page":"298","article-title":"Challenges in translating MMP inhibitors from bench to bedside","volume":"44","author":"Curran","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2025.118540_bib206","article-title":"Lessons from failed MMP inhibitors and emerging design strategies","volume":"249","author":"Shiomi","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.118540_bib207","article-title":"Overcoming toxicity and selectivity limitations in MMP inhibitor development","volume":"274","author":"Nuti","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib208","first-page":"1159","article-title":"Clinical development of broad-spectrum MMP inhibitors","volume":"30","author":"Stetler-Stevenson","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118540_bib209","first-page":"9585","article-title":"Mechanism-driven selectivity optimization of MMP inhibitors","volume":"66","author":"Wilson","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib210","article-title":"Design of dual-acting MMP\u2013HDAC inhibitors for metastatic PDAC","volume":"277","author":"Verma","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib211","article-title":"Structure-based evolution of clinical candidates in MMP inhibitor design","volume":"94","author":"Rossi","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib212","article-title":"Selective targeting of MMP-12 in inflammatory pancreatic tumors","volume":"275","author":"Yiotakis","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib213","article-title":"Role of computational modeling in preclinical optimization of MMP inhibitors","volume":"91","author":"Lin","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib214","article-title":"Revisiting the pharmacophore for selective MMP inhibition in cancer","volume":"273","author":"Dive","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib215","first-page":"1219","article-title":"Drug repurposing opportunities for metalloproteinase inhibitors in PDAC","volume":"16","author":"Zhao","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2025.118540_bib216","first-page":"1831","article-title":"Machine learning in metalloproteinase inhibitor discovery","volume":"64","author":"Arora","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118540_bib217","article-title":"Role of AI-driven SAR in optimizing MMP inhibitors for selectivity and solubility","volume":"270","author":"Patel","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib218","first-page":"821","article-title":"Clinical update: MMP inhibitors in combination therapy for PDAC","volume":"93","author":"Roy","year":"2024","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118540_bib219","article-title":"Pharmacokinetics and bioavailability challenges of MMP inhibitors","volume":"273","author":"Santos","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib220","first-page":"115","article-title":"Recent progress in understanding MMP isoform selectivity","volume":"220","author":"Lang","year":"2024","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2025.118540_bib221","first-page":"1102","article-title":"Predictive biomarkers for MMP inhibitor therapy","volume":"30","author":"Duffy","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118540_bib222","article-title":"Translational models for evaluating MMP inhibition in pancreatic cancer","volume":"274","author":"Takai","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib223","article-title":"Next-generation MMP inhibitors: targeting active-site zinc through non-classical ZBGs","volume":"99","author":"Zhang","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118540_bib224","article-title":"Future of MMP inhibitor research: focus on isoform selectivity and clinical safety","volume":"276","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118540_bib225","article-title":"Emerging clinical applications of MMP inhibitors beyond oncology","volume":"15","author":"Luo","year":"2024","journal-title":"Front. Pharmacol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425013054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425013054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T01:07:18Z","timestamp":1773536838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425013054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":168,"alternative-id":["S0223523425013054"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118540","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scaffold optimization trends in matrix metalloproteinase inhibitors for selective pancreatic cancer Therapy\u2014A review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118540"}}